NCT02459405

Brief Summary

Anastomotic leak is a devastating complication of colorectal surgery. There is no widespread means of assessing the viability of a laparoscopic anastomosis. The investigators described recently the feasibility of microvascularisation assessment with near-infra red technology (NIR). The aim of this study is to look at the implementation of this technique in a wider prospective series of patients undergoing colorectal resection.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
504

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Mar 2013

Typical duration for phase_2

Geographic Reach
4 countries

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2013

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

April 4, 2015

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 2, 2015

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2016

Completed
Last Updated

May 4, 2021

Status Verified

May 1, 2021

Enrollment Period

2.9 years

First QC Date

April 4, 2015

Last Update Submit

May 2, 2021

Conditions

Keywords

Colorectal surgeryNear infraredIndocyanine greenanastomotic leakPrevention of leak

Outcome Measures

Primary Outcomes (1)

  • Anastomotic leak rate

    anastomotic leak rate at 30 post operative days

    first 30 days

Secondary Outcomes (5)

  • Time to perform the near infrared procedure

    during surgery

  • Time to get a near infrared signal

    during surgery

  • complication rate

    30 days

  • Mortality

    30 days

  • Alteration of the course of surgery due to insufficient vascularisation

    during surgery

Study Arms (1)

NIR anastomotic perfusion assessment

EXPERIMENTAL

Patient will have their anastomosis assessed after they receive 7.5 to 9 mg of Indocyanine green intravenously (at a concentration of 2.5mg/ml). The microvascularisation assessment will be performed using a near infrared device(Pinpoint device), allowing to increase reality. This procedure will be repeated twice during the surgery, the first time before and the second time after the anastomosis has been done.

Procedure: NIR anastomotic perfusion assessmentDevice: Near infrared camera

Interventions

Patient will have their anastomosis assessed by near infrared technology after indocyanine green has been injected i.v. The procedure will be repeated twice, once before the anastomosis and the second time after the anastomosis has been performed.

Also known as: Indocyanine assessment of anastomotic microvascularisation
NIR anastomotic perfusion assessment

Use of the Pinpoint laparoscopic scope (Novadaq, Vancouver, Canada) after injection of indocyanine green

Also known as: Pinpoint evaluation
NIR anastomotic perfusion assessment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participant is willing and able to give informed consent for participation in the study.
  • Participant willing and able to comply with the study procedures.
  • Diagnosed with required colon or rectal neoplasia requiring surgical excision by either laparoscopic or open surgery.
  • A negative pregnancy test for women of childbearing potential prior to surgery
  • Able (in the Investigators opinion) and willing to comply with all study requirements

You may not qualify if:

  • Female participant who is pregnant, lactating or planning pregnancy during the course of the study.
  • Allergy to Indocyanine green.
  • Participant who is undergoing purely palliative surgery or who is terminally ill
  • Subject has other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the study, or may influence the result of the study, or the participant's ability to participate in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Dublin University College, department of colorectal surgery

Dublin, 4, Ireland

Location

Humanitas Universtity Hospitals

Milan, Rozzano (Milano), Italy

Location

Geneva University Hospitals, Service of Visceral Surgery

Geneva, 1224, Switzerland

Location

Oxford University Hospitals, Department of colorectal Surgery

Oxford, Oxfordshire, OX3, United Kingdom

Location

Related Publications (3)

  • Ris F, Hompes R, Cunningham C, Lindsey I, Guy R, Jones O, George B, Cahill RA, Mortensen NJ. Near-infrared (NIR) perfusion angiography in minimally invasive colorectal surgery. Surg Endosc. 2014 Jul;28(7):2221-6. doi: 10.1007/s00464-014-3432-y. Epub 2014 Feb 25.

    PMID: 24566744BACKGROUND
  • Cahill RA, Ris F, Mortensen NJ. Near-infrared laparoscopy for real-time intra-operative arterial and lymphatic perfusion imaging. Colorectal Dis. 2011 Nov;13 Suppl 7:12-7. doi: 10.1111/j.1463-1318.2011.02772.x.

    PMID: 22098511BACKGROUND
  • Ris F, Liot E, Buchs NC, Kraus R, Ismael G, Belfontali V, Douissard J, Cunningham C, Lindsey I, Guy R, Jones O, George B, Morel P, Mortensen NJ, Hompes R, Cahill RA; Near-Infrared Anastomotic Perfusion Assessment Network VOIR. Multicentre phase II trial of near-infrared imaging in elective colorectal surgery. Br J Surg. 2018 Sep;105(10):1359-1367. doi: 10.1002/bjs.10844. Epub 2018 Apr 16.

MeSH Terms

Conditions

Anastomotic Leak

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Frederic Ris, MD, Prof

    University Hospital, Geneva

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PD

Study Record Dates

First Submitted

April 4, 2015

First Posted

June 2, 2015

Study Start

March 1, 2013

Primary Completion

February 1, 2016

Study Completion

February 1, 2016

Last Updated

May 4, 2021

Record last verified: 2021-05

Locations